Skip to main content
OpenTrials
Completed

NCT Number: NCT03617601

Metabolic Equivalent of Task (MET) in the Preoperative Assessment in Aortic Surgery

Reliable prediction of the preoperative risk is of crucial importance for patients undergoing vascular operations. The assessment of the metabolic equivalent of task (MET) is an easy clinical evaluation of the functional capacity of an individual. A MET is defined as the resting metabolic rate, that is the amount of the consumed oxygen at rest. According to the MET concept a patient would be considered as "fit for surgery" when the stairs of two flights can be climbed and the housework can be fully managed by oneself.

Hypothesis: Patients with a functional capacity over 4 MET (fit for surgery) have less perioperative complications with the focus on cardiac pathology than patients with less than 4 MET during aortic operations.

Patients and Method: Retrospective analysis of a single center unit of 296 patients undergoing open or endovascular aortic repair.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Data of all patients after open and endovascular aortic repair of the descending aorta from May 2009 till March 2016

Exclusion criteria

  • Data of all patients with isolated operations on the ascending aorta or aortic arch

Treatment and study plan

MET

Diagnostic Test

Testing of the metabolic equivalent of task before aortic procedure

Primary outcomes

  1. Survival

    Time frame: up to ten years

    Mean survival during the whole follow up period of both groups, patients with less and more than 4 MET

Secondary outcomes

  1. Perioperative complications

    Time frame: up to 30 days postoperatively

    Complications include perioperative myocardial infarction and stroke, re-operation during first admission (divided in greater and smaller re-operations)

  2. Coronary artery bypass grafting, percutaneous coronary intervention/Stenting

    Time frame: up to ten years

    Interventions including revascularisation or other kind of heart surgery or treatment because of cardiac pathology

Sponsors and collaborators

Lead sponsor

Triemli Hospital

Other

Registry information

Important dates

Study start
2009
Primary completion
2016
Study completion
2018
First posted
Aug 6, 2018
Registry last updated
Aug 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.